# Study Highlights Significant Cannabis Risk Knowledge Gaps Among Young Adults > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/study-highlights-significant-cannabis-risk-knowledge-gaps-among-young-adults/ > **Published:** 2026-05-12T09:14:51-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:55:41-04:00 > **Clinical Summary:** Study reveals cannabis risk awareness gaps among young adults. Learn what clinicians should counsel about brain development, CUD, and mental health. --- ✦ New CED Clinical Relevance** #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchMental HealthSafetyPediatrics Why This Matters Clinicians need to understand that young adults often lack accurate knowledge about cannabis risks, which may lead to underestimation of potential harms when patients self-report use or decline to disclose it. This knowledge gap directly impacts clinical assessment and counseling effectiveness, requiring providers to proactively educate patients about documented risks rather than assuming awareness. Addressing misconceptions during routine care can improve shared decision-making and help patients make informed choices about [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/). Clinical Summary A recent study examining cannabis risk awareness in young adults reveals substantial knowledge gaps about the health consequences of cannabis use, particularly regarding potential effects on cognitive development, mental health, and driving safety. Young adults demonstrate limited understanding of dose-dependent risks and the distinction between occasional and chronic use patterns, with many underestimating the potency of modern cannabis products, especially high-THC concentrates. These findings are clinically significant because inadequate risk perception among younger populations may contribute to delayed help-seeking behavior, underreporting of cannabis-related symptoms during clinical encounters, and reduced motivation for [harm reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/) strategies. Clinicians caring for adolescents and young adults should recognize this knowledge gap as a barrier to informed decision-making and view patient education about cannabis risks as a core preventive health intervention. For practitioners, routine assessment of cannabis use should be paired with structured counseling about specific health risks relevant to age, frequency of use, and product type to bridge this critical information gap and support evidence-based decision-making among young patients. Dr. Caplan’s Take “What we’re seeing in clinical practice mirrors this research exactly: young adults have absorbed the message that cannabis is safer than alcohol without understanding that safety is dose, frequency, and individual neurobiology dependent, and that’s creating a real problem for those with emerging psychosis risk or developing brains. Until we integrate honest [cannabis education](https://cedclinic.com/unlock-healing-potential-cannabis-audiobook/) into primary care and [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/), we’ll continue managing preventable psychiatric complications that could have been identified or avoided with basic risk stratification upfront.” Clinical Perspective This study identifying knowledge gaps about cannabis risks among young adults underscores a critical clinical education challenge, as patients may seek cannabis for symptom management without understanding potential harms including [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/), dependence, or drug interactions. Healthcare providers should recognize that limited public awareness about cannabis risks does not reflect the actual evidence base, which documents real concerns particularly for developing brains and vulnerable populations, though the magnitude of individual risk varies considerably based on age, frequency of use, product potency, and route of administration. The gap between public perception and clinical evidence is further complicated by evolving regulatory landscapes and inconsistent medical messaging across jurisdictions, which can undermine patient trust and shared decision-making. When counseling patients about cannabis use, clinicians should provide evidence-based risk information tailored to individual circumstances, assess baseline cognitive and mental health status, and remain alert to signs of problematic use patterns, while acknowledging genuine therapeutic interest and maintaining non-judgmental 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Study%20Highlights%20Significant%20Cannabis%20Risk%20Knowledge%20Gaps%20Among%20Young%20Adults%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D52308)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D52308)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Study%20Highlights%20Significant%20Cannabis%20Risk%20Knowledge%20Gaps%20Among%20Young%20Adults%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D52308)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [Survey: Americans Microdose Cannabis Far More Than Psychedelics – Ganjapreneur](https://cedclinic.com/survey-americans-microdose-cannabis-far-more-than-psychedelics-ganjapreneur/) - [Researchers Found Why CBD Affects Anxiety Differently in Each Person](https://cedclinic.com/variable-cbd-response-anxiety/) - [Girl Scouts troop draws buzz after runaway cookie sales outside cannabis** shop – AOL.com](https://cedclinic.com/cannabis-pediatric-safety-community-normalization/) 📰 Source: [https://hempgazette.com/news/cannabis-risk-knowledge-gaps-young-adults/](https://hempgazette.com/news/cannabis-risk-knowledge-gaps-young-adults/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).